Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Christopher Hook

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Blood Cancer Journal|March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemiaKebede H Begna, Walid Ali, Naseema Gangat, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
American Journal of Hematology|February 4, 2021
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosisGaurav Goyal, Jithma P Abeykoon, Marie Hu, et al.
Mayo Clinic Proceedings|August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented GroupRonald S Go, Jeffrey L Winters, Nelson Leung, et al.
Haematologica|June 20, 2024
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): the Mayo Clinic experienceClifford M Csizmar, Antoine N Saliba, Patricia T Greipp, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood Cancer Journal|June 20, 2024
Clinical features and outcomes in primary nervous system histiocytic neoplasmsNabeela Nathoo, Joon H Uhm, Alyx B Porter, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Blood Cancer Journal|March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemiaKebede H Begna, Walid Ali, Naseema Gangat, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
American Journal of Hematology|February 4, 2021
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosisGaurav Goyal, Jithma P Abeykoon, Marie Hu, et al.
Mayo Clinic Proceedings|August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented GroupRonald S Go, Jeffrey L Winters, Nelson Leung, et al.
Haematologica|June 20, 2024
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(<i>DEK::NUP214</i>): the Mayo Clinic experienceClifford M Csizmar, Antoine N Saliba, Patricia T Greipp, et al.
Mayo Clinic Proceedings|June 6, 2018
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical InformationAyalew Tefferi, Naseema Gangat, Mythri Mudireddy, et al.
Blood Cancer Journal|June 20, 2024
Clinical features and outcomes in primary nervous system histiocytic neoplasmsNabeela Nathoo, Joon H Uhm, Alyx B Porter, et al.
Pageof 5